View More Recent Stories

Apr 7, 2023 01:00AM Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023
Apr 7, 2023 01:00AM Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023
Apr 6, 2023 01:00AM Innate Pharma Files Its 2022 Universal Registration Document (Document d’enregistrement universel) and 2022 Annual Report on Form 20-F
Apr 6, 2023 01:00AM Innate Pharma Files Its 2022 Universal Registration Document (Document d’enregistrement universel) and 2022 Annual Report on Form 20-F
Apr 3, 2023 05:24AM Innate Pharma (IPHA) Announces Exclusive License of Antibodies to Takeda for Celiac Disease Research Program
Apr 3, 2023 01:00AM Innate Pharma Announces Exclusive License of Antibodies to Takeda for Celiac Disease Research Program
Apr 3, 2023 01:00AM Innate Pharma Announces Exclusive License of Antibodies to Takeda for Celiac Disease Research Program
Mar 23, 2023 05:29AM Innate Pharma (IPHA) Reports FY22, Provides Business Update
Mar 23, 2023 02:00AM Innate Pharma Reports Full Year 2022(1) Financial Results and Business Update
Mar 23, 2023 02:00AM Innate Pharma Reports Full Year 2022(1) Financial Results and Business Update
Nov 5, 2020 08:00AM Innate Pharma Launches HopeConnectLearn: A New Online Resource for Hairy Cell Leukemia Patients
Aug 11, 2020 01:00AM Innate Pharma Obtains €6.8M in Public Funding for Its COVID-19 Research And Development Activities
View More Recent Stories